PULMORPHIX LIMITED

L3 2AJ (North West)

Start Date End Date

Funded Value Relevance

CSV

25 50 100

£86,901

May 14 - Aug 15

The development of the world’s first lung biosimulator device to investigate orally inhaled products (OIPs) under deep lung conditions – A proof of concept project.

Innovate UK award to PULMORPHIX LIMITED and Kish Mistry

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}